Literature DB >> 17540846

Negative regulation of the SH2-homology containing protein-tyrosine phosphatase-1 (SHP-1) P2 promoter by the HTLV-1 Tax oncoprotein.

Jihua Cheng1, Andre R Kydd, Koichi Nakase, Kristin M Noonan, Akikazu Murakami, Hong Tao, Markryan Dwyer, Chen Xu, Quan Zhu, Wayne A Marasco.   

Abstract

Expression of SH(2)-homology-containing protein-tyrosine phosphatase-1 (SHP-1), a candidate tumor suppressor, is repressed in human T-cell leukemia virus type-1 (HTLV-1)-transformed lymphocyte cell lines, adult T-cell leukemia (ATL) cells, and in other hematologic malignancies. However, the mechanisms underlying regulation and repression of SHP-1 remain unclear. Herein, we cloned the putative full-length, hematopoietic cell-specific SHP-1 P2 promoter and identified the "core" promoter regions. HTLV-1 Tax profoundly represses P2 promoter activity and histone deacetylase-1 (HDAC1) potentiates such inhibition. NF-kappaB was implicated as both a rate-limiting factor for basal P2 promoter activity and important for Tax-induced promoter silencing (TIPS). Chromatin immunoprecipitation studies demonstrated that NF-kappaB dissociates from the SHP-1 P2 promoter following the binding of Tax and HDAC1. This is in agreement with coimmunoprecipitation studies where NF-kappaB competed with HDAC1 for association with Tax protein. We propose that in TIPS, Tax recruits HDAC1 to the SHP-1 P2 promoter and forms an inhibitory complex that results in deacetylation and dissociation of NF-kappaB from the promoter and attenuation of SHP-1 expression. TIPS provides a possible first step toward HTLV-1 leukemogenesis through its down-modulation of this key immediate early negative regulator of IL-2 signaling.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17540846      PMCID: PMC1976352          DOI: 10.1182/blood-2006-11-058388

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  82 in total

Review 1.  Inhibitors of cytokine signal transduction.

Authors:  Samuel Wormald; Douglas J Hilton
Journal:  J Biol Chem       Date:  2003-11-07       Impact factor: 5.157

2.  Polyubiquitination of p53 by a ubiquitin ligase activity of p300.

Authors:  Steven R Grossman; Maria E Deato; Chrystelle Brignone; Ho Man Chan; Andrew L Kung; Hideaki Tagami; Yoshihiro Nakatani; David M Livingston
Journal:  Science       Date:  2003-04-11       Impact factor: 47.728

Review 3.  Shaping the nuclear action of NF-kappaB.

Authors:  Lin-Feng Chen; Warner C Greene
Journal:  Nat Rev Mol Cell Biol       Date:  2004-05       Impact factor: 94.444

4.  Identification of HTLV-I tax trans-activator mutants exhibiting novel transcriptional phenotypes.

Authors:  M R Smith; W C Greene
Journal:  Genes Dev       Date:  1990-11       Impact factor: 11.361

5.  PDZ domain-binding motif of human T-cell leukemia virus type 1 Tax oncoprotein augments the transforming activity in a rat fibroblast cell line.

Authors:  Akira Hirata; Masaya Higuchi; Akiko Niinuma; Minako Ohashi; Masaya Fukushi; Masayasu Oie; Tetsu Akiyama; Yuetsu Tanaka; Fumitake Gejyo; Masahiro Fujii
Journal:  Virology       Date:  2004-01-05       Impact factor: 3.616

Review 6.  Human T-cell leukemia virus type I and adult T-cell leukemia.

Authors:  Masao Matsuoka
Journal:  Oncogene       Date:  2003-08-11       Impact factor: 9.867

7.  Dimerization of NF-KB2 with RelA(p65) regulates DNA binding, transcriptional activation, and inhibition by an I kappa B-alpha (MAD-3).

Authors:  C S Duckett; N D Perkins; T F Kowalik; R M Schmid; E S Huang; A S Baldwin; G J Nabel
Journal:  Mol Cell Biol       Date:  1993-03       Impact factor: 4.272

8.  Down-regulation of SHP1 and up-regulation of negative regulators of JAK/STAT signaling in HTLV-1 transformed cell lines and freshly transformed human peripheral blood CD4+ T-cells.

Authors:  Jihua Cheng; Dongsheng Zhang; Changhong Zhou; Wayne A Marasco
Journal:  Leuk Res       Date:  2004-01       Impact factor: 3.156

Review 9.  The function of the protein tyrosine phosphatase SHP-1 in cancer.

Authors:  Chengyu Wu; Mingzhong Sun; Lijun Liu; G Wayne Zhou
Journal:  Gene       Date:  2003-03-13       Impact factor: 3.688

10.  Inactivation of hTERT transcription by Tax.

Authors:  Anne-Sophie Gabet; Franck Mortreux; Pierre Charneau; Patrice Riou; Madeleine Duc-Dodon; Yalin Wu; Kuan-Teh Jeang; Eric Wattel
Journal:  Oncogene       Date:  2003-06-12       Impact factor: 9.867

View more
  13 in total

Review 1.  Towards incorporating epigenetic mechanisms into carcinogen identification and evaluation.

Authors:  Zdenko Herceg; Marie-Pierre Lambert; Karin van Veldhoven; Christiana Demetriou; Paolo Vineis; Martyn T Smith; Kurt Straif; Christopher P Wild
Journal:  Carcinogenesis       Date:  2013-06-07       Impact factor: 4.944

Review 2.  Human T-lymphotropic virus proteins and post-translational modification pathways.

Authors:  Carlo Bidoia
Journal:  World J Virol       Date:  2012-08-12

3.  Increased promoter methylation of the immune regulatory gene SHP-1 in leukocytes of multiple sclerosis subjects.

Authors:  Chiharu Kumagai; Bernadette Kalman; Frank A Middleton; Tamara Vyshkina; Paul T Massa
Journal:  J Neuroimmunol       Date:  2012-03-27       Impact factor: 3.478

4.  The phosphatase Shp2 is required for signaling by the Kaposi's sarcoma-associated herpesvirus viral GPCR in primary endothelial cells.

Authors:  Thomas Bakken; Meilan He; Mark L Cannon
Journal:  Virology       Date:  2009-12-09       Impact factor: 3.616

Review 5.  Peripheral T cell lymphomas: from the bench to the clinic.

Authors:  Danilo Fiore; Luca Vincenzo Cappelli; Alessandro Broccoli; Pier Luigi Zinzani; Wing C Chan; Giorgio Inghirami
Journal:  Nat Rev Cancer       Date:  2020-04-06       Impact factor: 60.716

6.  SHP-1 deficiency and increased inflammatory gene expression in PBMCs of multiple sclerosis patients.

Authors:  George P Christophi; Chad A Hudson; Ross C Gruber; Christoforos P Christophi; Cornelia Mihai; Luis J Mejico; Burk Jubelt; Paul T Massa
Journal:  Lab Invest       Date:  2008-01-21       Impact factor: 5.662

7.  Mechanisms of SHP-1 P2 promoter regulation in hematopoietic cells and its silencing in HTLV-1-transformed T cells.

Authors:  Koichi Nakase; Jihua Cheng; Quan Zhu; Wayne A Marasco
Journal:  J Leukoc Biol       Date:  2008-11-12       Impact factor: 4.962

Review 8.  Genetic profiling and biomarkers in peripheral T-cell lymphomas: current role in the diagnostic work-up.

Authors:  Francisco Vega; Catalina Amador; Amy Chadburn; Eric D Hsi; Graham Slack; L Jeffrey Medeiros; Andrew L Feldman
Journal:  Mod Pathol       Date:  2021-09-28       Impact factor: 7.842

9.  Macrophages of multiple sclerosis patients display deficient SHP-1 expression and enhanced inflammatory phenotype.

Authors:  George P Christophi; Michael Panos; Chad A Hudson; Rebecca L Christophi; Ross C Gruber; Akos T Mersich; Scott D Blystone; Burk Jubelt; Paul T Massa
Journal:  Lab Invest       Date:  2009-04-27       Impact factor: 5.662

Review 10.  Viral Manipulation of the Host Epigenome as a Driver of Virus-Induced Oncogenesis.

Authors:  Shimaa Hassan AbdelAziz Soliman; Arturo Orlacchio; Fabio Verginelli
Journal:  Microorganisms       Date:  2021-05-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.